Steward Partners Investment Advisory, LLC Cidara Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$1.99 - $3.25 $995 - $1,625	-500 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$2.85 - $4.1 $285 - $409	100 Added 25.0%	500 $1,000
Q2 2019 Jul 25, 2019	BUY	$1.49 - $2.94 $596 - $1,176	400 New	400 $0
Q4 2018 Jan 15, 2019	SELL	$2.1 - $4.5 $2,100 - $4,500	-1,000 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$3.7 - $5.25 $8,325 - $11,812	-2,250 Reduced 69.23%	1,000 $4,000
Q2 2018 Jul 20, 2018	BUY	$3.75 - $6.05 $12,187 - $19,662	3,250 New	3,250 $17,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.